TD Securities Sees Strong 2026 Growth for Tempus AI TD Cowen upgraded Tempus AI to Buy, $65 target, citing strong growth in AI pharma tools despite recent stock drop. Credit: Tempus AI Subscribe now Already have an account? Sign in.
